Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03125681
Other study ID # RIPC_multiplate
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 11, 2017
Est. completion date February 9, 2019

Study information

Verified date April 2019
Source Seoul National University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the effects of remote ischemic conditioning on platelet function during off-pump coronary artery bypass surgery.


Description:

Remote ischemic conditioning (RIC) may affect platelet function. However, little is known about effect of RIC on platelet function during off-pump coronary artery bypass surgery. In this study investigators are going to perform RIC after anesthesia induction (remote ischemic pre-conditioning) and after completion of coronary anastomoses (remote ischemic post-conditioning), and compare platelet function parameters with control group.


Recruitment information / eligibility

Status Completed
Enrollment 58
Est. completion date February 9, 2019
Est. primary completion date January 31, 2019
Accepts healthy volunteers No
Gender All
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria:

- 20 - 80 years of adult patient undergoing elective off-pump coronary artery bypass surgery

Exclusion Criteria:

- Acute Myocardial Infarction

- Recent (<1 month) coronary angioplasty (percutaneous coronary intervention, PCI)

- Acute cerebrovascular ischemia (<6 months)

- Preoperative LV EF < 30%, mechanical ventricular support (IABP, VAD, ECMO)

- Peripheral vascular disease

- Poorly controlled diabetes mellitus

- Alzheimer's disease

- NSAIDs within 3 days

- iv heparin within 6 h

- low molecular weight heparin within 24 h

- platelet inhibitor within 24 h

- known thrombocytopenia

- renal failure / hemodialysis

- active infection

- preoperative bleeding diathesis

- redo-operation

- pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Remote ischemic conditioning
In the RIC group, RIC is performed before and after coronary anastomoses by 5 minutes limb ischemia and reperfusion with pneumatic cuff up to 200 mmHg repeated by four times.
Control
In the control group, all the procedures will be same with RIC group, except for the fact that the three-way stopcock between the pneumatic cuff and the cuff inflator was opened and therefore the cuff pressure did not increase.

Locations

Country Name City State
Korea, Republic of Seoul National University Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change of Multiplate ADPtest AUC Area under the aggregation curve (AUC) after platelet stimulation with adenosine diphosphate Baseline, at the end of surgery, postoperative day 1
Secondary Change of Multiplate ASPItest AUC Area under the aggregation curve (AUC) after platelet stimulation with arachidonic acid Baseline, at the end of surgery, postoperative day 1
Secondary Change of Multiplate COLtest AUC Area under the aggregation curve (AUC) after platelet stimulation with collagen Baseline, at the end of surgery, postoperative day 1
Secondary Change of Rotational thromboelastometry EXTEM parameter Screening test for the extrinsic haemostasis system Baseline, at the end of surgery, postoperative day 1
Secondary Change of Rotational thromboelastometry FIBTEM parameter Represents an EXTEM based assay for the fibrin part of the clot Baseline, at the end of surgery, postoperative day 1
Secondary Rotational thromboelastometry INTEM parameter Intrinsically activated rotational thrombelastometry Baseline, at the end of surgery, postoperative day 1
Secondary Change of Rotational thromboelastometry HEPTEM parameter Represents an INTEM assay performed in the presence of heparinase Baseline, at the end of surgery, postoperative day 1
Secondary Amount of peri-operative bleeding and transfusion Amount of peri-operative bleeding and transfusion At the end of surgery, postoperative day 1,2,3
See also
  Status Clinical Trial Phase
Completed NCT01231035 - REsponsiveness to CLOpidogrel and Stent-related Events in Acute Coronary Syndromes (RECLOSE 2 - ACS) N/A
Not yet recruiting NCT03149250 - Characteristics of Primary and Plasmatic Hemostasis in Preeclampsia N/A
Completed NCT02594345 - Effect of Exosomes Derived From Red Blood Cell Units on Platelet Function and Blood Coagulation N/A
Recruiting NCT01881698 - Evaluation of Platelet Function in Pregnancy With Multiple Electrode Aggregometry N/A
Recruiting NCT01352923 - Study of Polymorphisms in pear1 Gene Link to Platelet Activation and Signaling Pathway Variations N/A
Completed NCT00748878 - Platelet Function During ECMO (Extra Corporeal Membrane Oxygenation) N/A
Completed NCT02215993 - Sampling P2Y12 Receptor Inhibition With Prasugrel and Ticagrelor in Patients Submitted to Thrombolysis Phase 4
Terminated NCT01428102 - RapidTEG MA Validation N/A
Completed NCT00976872 - Omega 3 Action on Cardiovascular Risk Factors in Patients Treated With Statins N/A
Completed NCT01112137 - Effects of Clopidogrel on Blood Pressure Phase 4
Completed NCT01019499 - The Effect of Berry Consumption on Indicators of Cardiovascular Disease Risk N/A
Completed NCT02997111 - PFA-100 Responsive to Effect of Energy Drinks on Platelet Function N/A
Completed NCT01837758 - Monitoring Platelet Function During Continuous Hemodialysis N/A
Completed NCT00861341 - Effects of Pioglitazone on Platelet Function Phase 2
Terminated NCT04456608 - Genetic and Dietary Predictors of Anti-platelet Response Phase 4